Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
June 09 2019 - 3:00PM
Business Wire
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage
biotechnology company focused on discovering and developing
innovative immuno-oncology protein therapeutics today announced
that Aron Knickerbocker, Chief Executive Officer, is scheduled
to present at the following two investor conferences:
- The Raymond James Life Sciences and
MedTech Conference, on Wednesday, June 19th at 1:15pm ET / 10:15am
PT
- The 2019 Bank of Montreal Prescriptions
for Success Healthcare Conference on Tuesday, June 25th at 3:00pm
ET / 12:00pm PT
The presentations will be webcast and may be accessed at the
“Events & Presentations” section of the Company’s website at:
http://investor.fiveprime.com/events.cfm. Five Prime will maintain
an archived replay of the webcast on its website for 30 days after
the conference.
About Five Prime
Five Prime Therapeutics, Inc. discovers and develops
innovative protein therapeutics to improve the lives of patients
with serious diseases. Five Prime’s product candidates have
innovative mechanisms of action and address patient populations in
need of better therapies. The company focuses on researching and
developing immuno-oncology and targeted cancer therapies paired
with companion diagnostics to identify patients who are most likely
to benefit from treatment with Five Prime’s product candidates.
Five Prime has entered into strategic collaborations with leading
global pharmaceutical companies and has promising product
candidates in clinical and preclinical development. For more
information, please visit www.fiveprime.com or follow us
on LinkedIn, Twitter and Facebook.
Source: Five Prime Therapeutics, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190609005022/en/
Media and Investor ContactMartin ForrestVP, Investor
Relations & Corporate CommunicationsFive Prime Therapeutics,
Inc.415-365-5625martin.forrest@fiveprime.com
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Jul 2023 to Jul 2024